Bioavailability of Orally Ingested Vitamin C

NCT ID: NCT05183880

Last Updated: 2024-05-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2021-11-26

Study Completion Date

2023-11-26

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine if crystalline vitamin C supplementation can acutely increase skeletal muscle vitamin C concentrations and if this can be potentiated by administering vitamin C using Phosphycell™ Technology - a phosphatidylcholine-lipid encapsulation technology.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Crystalline vitamin C supplementation

1000 mg of vitamin C ingested in crystalline form

Group Type ACTIVE_COMPARATOR

Crystalline vitamin C

Intervention Type DIETARY_SUPPLEMENT

Ingesting 1000 mg of vitamin C in crystalline form

Phosphatidylcholine-lipid encapsulated vitamin C supplementation

1000 mg of vitamin C ingested in phosphatidylcholine-lipid encapsulated form

Group Type EXPERIMENTAL

Phosphatidylcholine-lipid encapsulated vitamin C

Intervention Type DIETARY_SUPPLEMENT

Ingesting 1000 mg of vitamin C in phosphatidylcholine-lipid encapsulated form

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Phosphatidylcholine-lipid encapsulated vitamin C

Ingesting 1000 mg of vitamin C in phosphatidylcholine-lipid encapsulated form

Intervention Type DIETARY_SUPPLEMENT

Crystalline vitamin C

Ingesting 1000 mg of vitamin C in crystalline form

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Body mass index (BMI) 18.5 - 30 kg/m2
* Age 18 - 40
* Non-smoker

Exclusion Criteria

* Body mass index (BMI) \< 18.5 or \> 30 kg/m2
* Age \< 18 or \> 40
* Smoking
* Cardiovascular disease
* Hypertension (≥ 140/90 mmHg)
* Metabolic disease
* Medications known to affect vitamin C metabolism
* A known vitamin C deficiency
* Less than 2 hours per week of physical activity or following a structured exercise training program.
* Routine use of vitamin supplements
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Exeter

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Francis Stephens

Role: PRINCIPAL_INVESTIGATOR

University of Exeter

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sport and Health Sciences

Exeter, Devon, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

21-10-20-B-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effect of OPC Factor on Energy Levels
NCT00318019 COMPLETED PHASE2